Artidis is a clinical-stage medical technology company developing a nanotechnology platform for tissue analysis combined with a digital data platform, intended for broad use in drug discovery, tissue engineering, rapid diagnostics, and personalized treatment.
1
Funding Rounds
$8.8m
Money raised
Access comprehensive data and insights available only to Seedtable members
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
The company Artidis has raised a total of $8.8m in funding over 1 rounds.